A review of the literature on neuroimaging of serotoninergic function in Alzheimer's disease and related disorders

[en] Behavioural and psychological disorders are frequent not only in frontotemporal dementia (FTD), but also in Alzheimer's disease (AD), and many of them are related to serotoninergic dysfunction. In vitro biochemical measurements on brain samples show both pre- and post-synaptic impaired brain serotoninergic function in degenerative dementia, sometimes related to hyperactivity or aggressive behaviour. To date, few studies have explored in vivo 5HT2A and 5HT1A brain receptors in AD and FTD. They suggest that brain cells are lost in the associative cortices (5HT2A) and hippocampus (5HT1A) of AD patients, and in the medial prefrontal and orbitofrontal cortices of FTD subjects (5HT2A). Apart from reflecting a loss of local neurons, the meaning of the decrease in 5HT receptors is not yet clear and larger populations are required to establish relationships with clinical symptoms such as dementia severity and search for possible consequences for patients' behavioural and affective status.

Research center :

European program DIMI

Disciplines :

Neurosciences & behavior
Neurology

Author, co-author :

Salmon, Eric ; Université de Liège - ULiège > Département des sciences cliniques > Neuroimagerie des troubles de la mémoire et révalid. cogn.

Language :

English

Title :

A review of the literature on neuroimaging of serotoninergic function in Alzheimer's disease and related disorders

Publication date :

September 2007

Journal title :

Journal of Neural Transmission

ISSN :

0300-9564

eISSN :

1435-1463

Publisher :

Springer Wien, Wien, Austria

Volume :

114

Issue :

Pages :

1179-1185

Peer reviewed :

Peer Reviewed verified by ORBi

Additional URL :

http://www.springerlink.com/content/r58164r8t977/?sortorder=asc&p_o=10

Funders :

F.R.S.-FNRS - Fonds de la Recherche Scientifique [BE]

Available on ORBi :

since 28 January 2009

Statistics

Number of views

91 (5 by ULiège)

Number of downloads

2 (2 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

S Abrahams LH Goldstein JJ Kew DJ Brooks CM Lloyd CD Frith PN Leigh 1996 Frontal lobe dysfunction in amyotrophic lateral sclerosis. A PET study Brain 119 Pt 6 2105 2120
KH Adams LH Pinborg C Svarer SG Hasselbalch S Holm S Haugbol K Madsen V Frokjaer L Martiny OB Paulson 2004 A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables Neuroimage 21 3 1105 1113
F Biver S Goldman A Luxen M Monclus M Forestini J Mendlewicz F Lotstra 1994 Multicompartmental study of fluorine-18 altanserin binding to brain 5HT2 receptors in humans using positron emission tomography Eur J Nucl Med 21 9 937 946
J Blin JC Baron B Dubois C Crouzel M Fiorelli D Attar-Levy B Pillon D Fournier M Vidailhet Y Agid 1993 Loss of brain 5-HT2 receptors in Alzheimer's disease. In vivo assessment with positron emission tomography and [18F]setoperone Brain 116 Pt 3 497 510
DM Bowen SJ Allen JS Benton MJ Goodhardt EA Haan AM Palmer NR Sims CC Smith JA Spillane MM Esiri 1983 Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease J Neurochem 41 1 266 272
MC Buhot S Martin L Segu 2000 Role of serotonin in memory impairment Ann Med 32 3 210 221
CP Chen SL Eastwood T Hope B [tmp] McDonald PT Francis MM Esiri 2000 Immunocytochemical study of the dorsal and median raphe nuclei in patients with Alzheimer's disease prospectively assessed for behavioural changes Neuropathol Appl Neurobiol 26 4 347 355
YH Chou C Halldin L Farde 2003 Occupancy of 5-HT1A receptors by clozapine in the primate brain: a PET study Psychopharmacology (Berl) 166 3 234 240
DC Chugani O Muzik P Chakraborty T Mangner HT Chugani 1998 Human brain serotonin synthesis capacity measured in vivo with alpha-[C-11]methyl-L- tryptophan Synapse 28 1 33 43
AJ Cross TJ Crow JA Johnson EK Perry RH Perry G Blessed BE Tomlinson 1984 Studies on neurotransmitter receptor systems in neocortex and hippocampus in senile dementia of the Alzheimer-type J Neurol Sci 64 2 109 117
SP David NV Murthy EA Rabiner MR Munafo EC Johnstone R Jacob RT Walton PM Grasby 2005 A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans J Neurosci 25 10 2586 2590
JB Deakin S Rahman PJ Nestor JR Hodges BJ Sahakian 2004 Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial Psychopharmacology (Berl) 172 4 400 408
MF Folstein SE Folstein PR [tmp] McHugh 1975 "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 3 189 198
M Franceschi D Anchisi O Pelati M Zuffi M Matarrese RM Moresco F Fazio D Perani 2005 Glucose metabolism and serotonin receptors in the frontotemporal lobe degeneration Ann Neurol 57 2 216 225
M Garcia-Alloza FJ Gil-Bea M Diez-Ariza CP Chen PT Francis B Lasheras MJ Ramirez 2005 Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease Neuropsychologia 43 3 442 449
G Garraux E Salmon C Degueldre C Lemaire S Laureys G Franck 1999 Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal dementia Neuroimage 10 2 149 162
PF Goyer MS Berridge ED Morris WE Semple BA Compton-Toth SC Schulz DF Wong F Miraldi HY Meltzer 1996 PET measurement of neuroreceptor occupancy by typical and atypical neuroleptics J Nucl Med 37 7 1122 1127
GM Halliday HL [tmp] McCann R Pamphlett WS Brooks H Creasey E [tmp] McCusker RG Cotton GA Broe CG Harper 1992 Brain stem serotonin-synthesizing neurons in Alzheimer's disease: a clinicopathological correlation Acta Neuropathol (Berl) 84 6 638 650
M Hendricksen AJ Thomas IN Ferrier P Ince JT O'Brien 2004 Neuropathological study of the dorsal raphe nuclei in late-life depression and Alzheimer's disease with and without depression Am J Psychiatry 161 6 1096 1102
K Herholz E Salmon D Perani JC Baron V Holthoff L Frolich P Schonknecht K Ito R Mielke E Kalbe 2002 Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET Neuroimage 17 1 302 316
E Hirani J Opacka-Juffry R Gunn I Khan T Sharp S Hume 2000 Pindolol occupancy of 5-HT(1A) receptors measured in vivo using small animal positron emission tomography with carbon-11 labeled WAY 100635 Synapse 36 4 330 341
C Holmes MJ Arranz JF Powell DA Collier S Lovestone 1998 5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease Hum Mol Genet 7 9 1507 1509
WS Huang KH Ma CY Cheng CY Chen YK Fu YH Chou SP Wey JC Liu 2004 Imaging serotonin transporters with 123I-ADAM brain SPECT in healthy non-human primates Nucl Med Commun 25 5 515 519
S Jovkar K Wienhard HH Coenen G Pawlik WD Heiss 1991 Quantification of baboon cortical S2 serotonin receptors in vivo with 3-N-(2′-F18) fluoroethylspiperone and positron emission tomography Eur J Nucl Med 18 3 158 163
T Kakiuchi S Nishiyama K Sato H Ohba S Nakanishi H Tsukada 2000 Age-related reduction of [11C]MDL100,907 binding to central 5-HT(2A) receptors: PET study in the conscious monkey brain Brain Res 883 1 135 142
V Kepe JR Barrio SC Huang L Ercoli P Siddarth K Shoghi-Jadid GM Cole N Satyamurthy JL Cummings GW Small 2006 Serotonin 1A receptors in the living brain of Alzheimer's disease patients Proc Natl Acad Sci USA 103 3 702 707
H Kristiansen B Elfving P Plenge LH Pinborg N Gillings GM Knudsen 2005 Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907 Synapse 58 4 249 257
A Kugaya CN Epperson S Zoghbi CH van Dyck Y Hou M Fujita JK Staley PK Garg JP Seibyl RB Innis 2003 Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women Am J Psychiatry 160 8 1522 1524
JT Kuikka J Tiihonen KA Bergstrom J Karhu P Hartikainen H Viinamaki E Lansimies J Lehtonen P Hakola 1995 Imaging of serotonin and dopamine transporters in the living human brain Eur J Nucl Med 22 4 346 350
MK Lai SW Tsang PT Francis MM Esiri J Keene T Hope CP Chen 2003 Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease Brain Res 974 1-2 82 87
MK Lai SW Tsang JT Alder J Keene T Hope MM Esiri PT Francis CP Chen 2005 Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer's disease Psychopharmacology (Berl) 179 3 673 677
F Lebert F Pasquier H Petit 1994 Behavioral effects of trazodone in Alzheimer's disease J Clin Psychiatry 55 12 536 538
F Lebert W Stekke C Hasenbroekx F Pasquier 2004 Frontotemporal dementia: a randomised, controlled trial with trazodone Dement Geriatr Cogn Disord 17 4 355 359
C Lemaire R Cantineau M Guillaume A Plenevaux L Christiaens 1991 Fluorine-18-altanserin: a radioligand for the study of serotonin receptors with PET: radiolabeling and in vivo biologic behavior in rats J Nucl Med 32 12 2266 2272
DE Lorke G Lu E Cho DT Yew 2006 Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients BMC Neurosci 7 36
AC Ludolph KJ Langen M Regard H Herzog B Kemper T Kuwert IG Bottger L Feinendegen 1992 Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study Acta Neurol Scand 85 2 81 89
CG Lyketsos JM Sheppard CD Steele S Kopunek M Steinberg AS Baker J Brandt PV Rabins 2000 Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: initial results from the depression in Alzheimer's disease study Am J Psychiatry 157 10 1686 1689
J Maeda T Suhara M Ogawa T Okauchi K Kawabe MR Zhang J Semba K Suzuki 2001 In vivo binding properties of [carbonyl-11C]WAY-100635: effect of endogenous serotonin Synapse 40 2 122 129
J Marksteiner T Walch T Bodner P Gurka E Donnemiller 2003 Fluoxetine in Alzheimer's disease with severe obsessive compulsive symptoms and a low density of serotonin transporter sites Pharmacopsychiatry 36 5 207 209
CA Mathis NR Simpson K Mahmood PE Kinahan MA Mintun 1994 [11C]WAY 100635: a radioligand for imaging 5-HT1A receptors with positron emission tomography Life Sci 55 20 PL403 PL407
CC Meltzer G Smith JC Price CF Reynolds 3rd CA Mathis P Greer B Lopresti MA Mintun BG Pollock D Ben-Eliezer 1998 Reduced binding of [18F]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction Brain Res 813 1 167 171
CC Meltzer JC Price CA Mathis PJ Greer MN Cantwell PR Houck BH Mulsant D Ben-Eliezer B Lopresti ST DeKosky 1999 PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders Am J Psychiatry 156 12 1871 1878
S Minoshima NL Foster DE Kuhl 1994 Posterior cingulate cortex in Alzheimer's disease Lancet 344 8926 895
R Moretti P Torre RM Antonello G Cazzato A Bava 2003 Frontotemporal dementia: paroxetine as a possible treatment of behavior symptoms. A randomized, controlled, open 14-month study Eur Neurol 49 1 13 19
B Nacmias A Tedde P Forleo S Piacentini BM Guarnieri A Bartoli L Ortenzi C Petruzzi A Serio G Marcon 2001 Association between 5-HT(2A) receptor polymorphism and psychotic symptoms in Alzheimer's disease Biol Psychiatry 50 6 472 475
JM Palacios C Waeber D Hoyer G Mengod 1990 Distribution of serotonin receptors Ann N Y Acad Sci 600 36 52
AM Palmer ST DeKosky 1993 Monoamine neurons in aging and Alzheimer's disease J Neural Transm Gen Sect 91 2-3 135 159
AM Palmer PT Francis JS Benton NR Sims DM Mann D Neary JS Snowden DM Bowen 1987 Presynaptic serotonergic dysfunction in patients with Alzheimer's disease J Neurochem 48 1 8 15
J Passchier A van Waarde RM Pieterman PH Elsinga J Pruim HN Hendrikse AT Willemsen W Vaalburg 2000 In vivo delineation of 5-HT1A receptors in human brain with [18F]MPPF J Nucl Med 41 11 1830 1835
A Plenevaux C Lemaire J Aerts G Lacan D Rubins WP Melega C Brihaye C Degueldre S Fuchs E Salmon 2000 [(18)F]p-MPPF: a radiolabeled antagonist for the study of 5-HT(1A) receptors with PET Nucl Med Biol 27 5 467 471
AW Procter M Qurne PT Francis 1999 Neurochemical features of frontotemporal dementia Dement Geriatr Cogn Disord 10 Suppl 1 80 84
GP Reynolds L Arnold MN Rossor LL Iversen CQ Mountjoy M Roth 1984 Reduced binding of [3H]ketanserin to cortical 5-HT2 receptors in senile dementia of the Alzheimer type Neurosci Lett 44 1 47 51
A Rosier P Dupont J Peuskens G Bormans R Vandenberghe M Maes T de Groot C Schiepers A Verbruggen L Mortelmans 1996 Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging Psychiatry Res 68 1 11 22
SM Rosso G Roks M Stevens I de Koning HLJ Tanghe W Kamphorst R Ravid MF Niermeijer JC van Swieten 2001 Complex compulsive behaviour in the temporal variant of frontotemporal dementia J Neurol 248 11 965 970
E Salmon G Garraux X Delbeuck F Collette E Kalbe G Zuendorf D Perani F Fazio K Herholz 2003 Predominant ventromedial frontopolar metabolic impairment in frontotemporal dementia Neuroimage 20 1 435 440
DL Sukonick BG Pollock RA Sweet BH Mulsant J Rosen WE Klunk KB Kastango ST DeKosky RE Ferrell 2001 The 5-HTTPR*S/*L polymorphism and aggressive behavior in Alzheimer disease Arch Neurol 58 9 1425 1428
JR Swartz BL Miller IM Lesser AL Darby 1997 Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors J Clin Psychiatry 58 5 212 216
AJ Thomas M Hendriksen M Piggott IN Ferrier E Perry P Ince JT O'Brien 2006 A study of the serotonin transporter in the prefrontal cortex in late-life depression and Alzheimer's disease with and without depression Neuropathol Appl Neurobiol 32 3 296 303
MR Turner EA Rabiner A Hammers A Al-Chalabi PM Grasby CE Shaw DJ Brooks PN Leigh 2005 [11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS Brain 128 Pt 4 896 905
J Versijpt KJ Van Laere F Dumont D Decoo M Vandecapelle P Santens I Goethals K Audenaert G Slegers RA Dierckx 2003 Imaging of the 5-HT2A system: age-, gender-, and Alzheimer's disease-related findings Neurobiol Aging 24 4 553 561
DF Wong JR Lever PR Hartig RF Dannals V Villemagne BJ Hoffman AA Wilson HT Ravert JM Links U Scheffel 1987 Localization of serotonin 5-HT2 receptors in living human brain by positron emission tomography using N1-([11C]-methyl)-2-Br- LSD Synapse 1 5 393 398
T Yamamoto A Hirano 1985 Nucleus raphe dorsalis in Alzheimer's disease: neurofibrillary tangles and loss of large neurons Ann Neurol 17 6 573 577
Y Yang HP Schmitt 2001 Frontotemporal dementia: evidence for impairment of ascending serotoninergic but not noradrenergic innervation. Immunocytochemical and quantitative study using a graph method Acta Neuropathol (Berl) 101 3 256 270
JA Yesavage TL Brink TL Rose O Lum V Huang M Adey O Leirer 1983 Development and validation of a geriatric depression screening scale: a preliminary report J Psychiatr Res 17 37 49
RM Zweig CA Ross JC Hedreen C Steele JE Cardillo PJ Whitehouse MF Folstein DL Price 1989 Neuropathology of aminergic nuclei in Alzheimer's disease Prog Clin Biol Res 317 353 365